News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024
Presentation EuroPCR 2024 Short Methodology Insight - NOTION-2 Presenter: Davide Capodanno May 14, 2024
News Conference News EuroPCR 2022 CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial Yael L. Maxwell May 24, 2022
News Conference News EuroPCR 2018 ‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease Yael L. Maxwell May 22, 2018